To target the untargetable : elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
| Errataetall: |
CommentOn: Haematologica. 2020 Jun;105(6):1539-1551. - PMID 31488557 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:105 |
|---|---|
| Enthalten in: |
Haematologica - 105(2020), 6 vom: 01. Juni, Seite 1470-1472 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sallman, David A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Azacitidine |
|---|
| Anmerkungen: |
Date Completed 24.03.2021 Date Revised 24.11.2021 published: Print CommentOn: Haematologica. 2020 Jun;105(6):1539-1551. - PMID 31488557 Citation Status MEDLINE |
|---|
| doi: |
10.3324/haematol.2020.249060 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310631440 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310631440 | ||
| 003 | DE-627 | ||
| 005 | 20231225140516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3324/haematol.2020.249060 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1035.xml |
| 035 | |a (DE-627)NLM310631440 | ||
| 035 | |a (NLM)32482751 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sallman, David A |e verfasserin |4 aut | |
| 245 | 1 | 3 | |a To target the untargetable |b elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2021 | ||
| 500 | |a Date Revised 24.11.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Haematologica. 2020 Jun;105(6):1539-1551. - PMID 31488557 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Quinuclidines |2 NLM | |
| 650 | 7 | |a TP53 protein, human |2 NLM | |
| 650 | 7 | |a Tumor Suppressor Protein p53 |2 NLM | |
| 650 | 7 | |a Azacitidine |2 NLM | |
| 650 | 7 | |a M801H13NRU |2 NLM | |
| 650 | 7 | |a eprenetapopt |2 NLM | |
| 650 | 7 | |a Z41TGB4080 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t Haematologica |d 1947 |g 105(2020), 6 vom: 01. Juni, Seite 1470-1472 |w (DE-627)NLM000081892 |x 1592-8721 |7 nnns |
| 773 | 1 | 8 | |g volume:105 |g year:2020 |g number:6 |g day:01 |g month:06 |g pages:1470-1472 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3324/haematol.2020.249060 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 105 |j 2020 |e 6 |b 01 |c 06 |h 1470-1472 | ||